RECRUITING

Data Collection and Evaluation of OptiBP Under Investigational Use

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.

Official Title

Data Collection and Evaluation of a Mobile, Machine-learning-based Solution for Blood Pressure Estimation - the OptiBP Study.

Quick Facts

Study Start:2023-09-28
Study Completion:2026-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06017687

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Be at least 18 years old (at least 19 years old in Alabama and Nebraska, at least 21 years old in Puerto Rico);
  2. 2. Live in the United States of America
  3. 3. Have an Android smartphone
  4. 4. Have access to an arm-worn blood pressure monitor (cuff)
  5. 5. Have access to the Google Play store to download the OptiBP study app on their phone
  6. 6. Be comfortable communicating in written and spoken English
  7. 7. Be willing and able to provide informed consent to participate in the study
  1. 1. Known contact dermatitis to nickel/chromium
  2. 2. Lesion or deficiency on hand, preventing placing a finger on the smartphone camera
  3. 3. Known dysrhythmia like bigeminy, trigeminy, isolated VPB, atrial fibrillation

Contacts and Locations

Study Contact

Frederic Frappereau
CONTACT
650-229-8604
study@biospectal.com

Principal Investigator

Frederic Frappereau
PRINCIPAL_INVESTIGATOR
Biospectal

Study Locations (Sites)

Decentralized Trial
Truckee, California, 96161
United States

Collaborators and Investigators

Sponsor: Biospectal

  • Frederic Frappereau, PRINCIPAL_INVESTIGATOR, Biospectal

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-28
Study Completion Date2026-09

Study Record Updates

Study Start Date2023-09-28
Study Completion Date2026-09

Terms related to this study

Additional Relevant MeSH Terms

  • General Population